Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,159 | -78,715 | -55,944 | -37,518 | -16,509 |
| Depreciation Amortization | 293 | 2,246 | 1,869 | 1,321 | 670 |
| Other Working Capital | -3,797 | 4,073 | 1,462 | -878 | -1,806 |
| Other Operating Activity | 3,945 | 12,855 | 9,356 | 5,960 | 2,744 |
| Operating Cash Flow | $-22,718 | $-59,541 | $-43,257 | $-31,115 | $-14,901 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -89,937 | 159,374 | 158,634 | 123,329 | 40,829 |
| PPE Investments | -723 | -939 | -550 | -317 | -182 |
| Investing Cash Flow | $-90,660 | $158,435 | $158,084 | $123,012 | $40,647 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16 | 50,986 | 50,173 | 74 | 16 |
| Other Financing Activity | 0 | -1,852 | -1,852 | -339 | 0 |
| Financing Cash Flow | $16 | $49,134 | $48,321 | $-265 | $16 |
| Beginning Cash Position | 226,474 | 78,446 | 78,446 | 78,446 | 78,446 |
| End Cash Position | 113,112 | 226,474 | 241,594 | 170,078 | 104,208 |
| Net Cash Flow | $-113,362 | $148,028 | $163,148 | $91,632 | $25,762 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,718 | -59,541 | -43,257 | -31,115 | -14,901 |
| Capital Expenditure | -723 | -939 | -550 | -317 | -182 |
| Free Cash Flow | -23,441 | -60,480 | -43,807 | -31,432 | -15,083 |